Europe
A decision by the Paris Central Division will lead to more IP work for outside counsel, say sources
Courts are encouraged to deliver judgments within three months of a trial, but that deadline has been missed in several recent cases
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Back-to-back PE deals for IP firms in recent years show that IP firms are sitting on goldmines, so traditional partnerships should be open to change
Sponsored
Sponsored
-
Sponsored by MaiwaldChristian Meyer and Gisela Grabow of Maiwald discuss potential changes to the EU pharmaceutical regulation and their potential impact on data and market protection timelines for medicinal products -
Sponsored by InspicosJakob Pade Frederiksen of Inspicos says a Unified Patent Court decision not to stay a revocation action while a parallel EPO opposition proceeding takes place provides another indication of the court’s fast pace
-
Sponsored by Bird & BirdEmilia Zalewska and Andrzej Stelmachowski of Bird & Bird provide insights into two matters considered by the Unified Patent Court and a Polish court concerning the imminent infringement of patent rights in the pharmaceutical industry
-
Sponsored by Patrinos & KilimirisManolis Metaxakis of Patrinos & Kilimiris reports on a notable judgment in the Zara trademark dispute, highlighting a radical provision in the relevant Greek legislation and the ruling’s alignment with EU case law
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos reviews a recent decision of the EPO Legal Board of Appeal relating to the impact of an applicant’s appeal against a decision to grant a patent
-
Sponsored by Bird & BirdMeyke Rietveld and Clemens Molle of Bird & Bird, along with Emma Ren from the association team at Beijing Lawjay Partners, discuss the first copyright cases in China and the EU dealing with training AI models, and newly enacted legislation in this field
European Jurisdictions